Stock Analysis

Some of these analyses are published here on the Dividend Drive. Others are published on websites such as Seeking Alpha (see my profile for more). Below I have arranged them by company including, where appropriate, London (LSE) or New York (NYSE) Stock Exchanges or the NASDAQ.

First, I also have a few which are more strategy related:

• How Do You (Roughly) Value A Pharmaceutical Pipeline? A Simple Suggestion (5/16)
• FCF Prediction: A Simple Method To Generate A Fairer Free Cash Flow Estimate (5/16)
• Credit Rating Analysis: A Simple Way To Quantify And Compare Company Credit Ratings (1/16)

And now, here are the company-specific pieces:

Accenture (NYSE:ACN)

• Accenture: Why The 5% Yield Is Just The Tip Of The Iceberg (2/16)

Altria (NYSE:MO)

• Altria: Can Cash Flow Clear Up My Confusion? (3/16)
• Altria: A Confusing Consumer Conglomerate I Can't Make Up My Mind About (3/16)

ARM Holdings (LSE:ARM) (NASDAQ:ARMH)

• ARM: Is There A Worry On Licenses Hidden In First-Quarter Results? (5/16)
• ARM Holdings: After Stock Drop Should You Buy This Low-Yielding, Highly Valued Tech Company? (2/16)

AT&T (NYSE:T)

• AT&T (T) vs. Verizon (VZ): Which Blue Chip Telecoms Play Should You Buy Today? (2/16)
• The FCF 5: Does AT&T Pass My 5 Free Cash Flow Tests? (1/16)

Boeing Company (NYSE:BA)

• The FCF 5: Does Boeing Pass My 5 Free Cash Flow Tests? (4/16)

Brown-Forman (NYSE:BF.B) (NYSE:BF.A)

• Brown-Forman: Quality At A Fair Value (5/16)
• Brown-Forman: Q3 2016 Results Are Solid If Unspectacular - An Opportunity To Buy? (3/16)
• Brown-Forman: Are We Overlooking The Hidden High Yield At This Consumer Defensive? (2/16)
• Brown-Forman Corp: Top Spirits Sector Performer, But Wait For A Price Drop (12/15)

Burberry (LSE:BRBY) (OTC:BURBY)

• Burberry: Did Investors Overreact To 2016 Results From This Fashion Icon? (5/16)
• Is A Buyer Looking To Try Burberry On For Size And What Should You Do? (3/16)
• Burberry: Share Price Declines At Highly Cash-Generative British Luxury Fashion Icon Presents A Long-Term Opportunity (1/16)

Campbell Soup Co (NYSE:CPB)

• Campbell Soup: H1 2016 Results Were Solid With Strong Cash Flow Performance (Still Overpriced Though) (3/16)
• Food Fight, Part 3: Campbell Soup Is A Super Business, But Currently Still Overvalued (1/16)

Caterpillar (NYSE:CAT)

• The FCF 5: Does Caterpillar Pass My 5 Free Cash Flow Tests? (5/16)

Church & Dwight (NYSE:CHD)

• Church & Dwight: Q1 2016 Results Leave Me Itching To Buy (5/16)
• Church & Dwight: Brand Portfolio Looks Great, But Valuation Doesn't (2/16)

Coca-Cola (NYSE:KO)

• Coca-Cola's (KO) 3% Dividend Yield Is Just The Beginning - The Power of the Buyback Is Clear (2/16)
• Coca-Cola Vs. PepsiCo: Both Great Companies But Both Are Running 11% Ahead Of Fair Value (12/15)

Colgate-Palmolive (NYSE:CL)

• Colgate-Palmolive: Should You Buy This Attractive Consumer Staple Dividend Aristocrat? (12/15)

Diageo (LSE:DGE) (NYSE:DEO)

• Diageo: Is It An Attractive Time To Build Up A Position In This Spirit Giant? (5/16)
• Diageo: Long-Term Growth Story Even More Compelling After First Half Results (2/16)
• Diageo: A Healthy And Attractive Long-Term Defensive Buy, But Wait For A 5% To 10% Pullback (12/15)

Dover Corporation (NYSE:DOV)

• The FCF 5: Does Dividend Aristocrat Dover Corporation Pass My 5 Free Cash Flow Tests? (3/16)

Dr Pepper Snapple (NYSE:DPS)

• Dr Pepper Snapple Group - Q1 2016 Results Looks Excellent, But Watch For Volumes (5/16)
• Dr Pepper Snapple: Am I Right To Have Overlooked This For PepsiCo And Coca-Cola? (3/16)

Estee Lauder (NYSE:EL)

• Estée Lauder: First-Half Results Show This Top-Performing Company Remains A Compelling Buy Right Now (3/16)
• Estée Lauder: A High-Class Business Beauty Trading 10% Below Fair Value (12/15)

Experian (LSE:EXPN) (NYSE:EXPGY)

• Experian: Brazilian Operations Present Problems But Strong Cash Generation Presents A Long-Term Opportunity (3/16)

Ford Motor Company (NYSE:F)

• The FCF 5: Does Ford Motor Company Pass My 5 Free Cash Flow Tests? (4/16)
• Dear Ford Motor Company: Sorry I Misunderstood Your Debt For So Long (4/16)

General Mills (NYSE:GIS)

• General Mills: A Work In Progress (3/16)
• Food Fight, Part 5: General Mills Compares Well To Its Peers And Is (Relatively) Fairly Valued (1/16)

General Motors (NYSE:GM)

• The FCF 5: Does GM Pass All 5 Of My Free Cash Flow Tests? (5/16)

GlaxoSmithKline (LSE:GSK) (NYSE:GSK)

• GlaxoSmithKline: A Cash Flow Caution To Dividend Investors? (5/16)
• Has The Momentum Finally Turned For GlaxoSmithKline? (4/16)

Hasbro (NYSE:HAS)

• Hasbro: Strong 2015 Results From An Attractive Company - Is It A Good Time To Buy? (2/16)
• Mattel Vs. Hasbro: Which Toy And Games Giant Should You Add To Your Portfolio? (12/15)

Hershey Company (NYSE:HSY)

• Hershey Company: Undervalued Per Long-Term Data? (5/16)
• Hershey's Valuation: Finding The Sweet Spot (5/16)
• Hershey: After Slightly Bitter Q1 Results, Is There Still Some Sweetness Left? (5/16)
• Hershey's Shanghai Acquisition Still A 'Golden Monkey' (4/16)

Honeywell International (NYSE:HON)

• Is Honeywell International Inc Still A Good Buy After Its Q1 2016 Results? (4/16)
• Should I Invest in Honeywell Or United Technologies? (3/16)

Hormel Foods (NYSE:HRL)

• Food Fight, Part 4: Dividend Aristocrat Hormel Foods Is Highly Attractive, Just Not At This Price (1/16)

Intercontinental Exchange (NYSE:ICE)

• Have I Unfairly Overlooked NASDAQ And Intercontinental Exchange? (4/16)

J. M. Smucker (NYSE:SJM)

• Food Fight, Part 2: J. M. Smucker Is An Excellent Company, But Just Watch It For Now (1/16)

Johnson & Johnson (NYSE:JNJ)

• Is Johnson & Johnson Attractively Valued Right Now? (5/16)
• Johnson & Johnson: An Almost Unbeatable, Diversified Healthcare Play Sitting Nearly 10% Below Fair Value (12/15)

Kelloggs (NYSE:K)

• Food Fight, Part 8: Kellogg Is Robust But Not Without Challenges (3/16)

Lancaster Colony (NASDAQ:LANC)

• Lancaster Colony: A Share Price Drop Of 15% On Q2 Results; Time To Buy? (1/16)
• Food Fight, Part 1: Wait For A Pullback In Small But Mighty Lancaster Colony (12/15)

Lockheed Martin (NYSE:LMT)

• The FCF 5: Does Lockheed Martin Pass? (3/16)

MasterCard (NYSE:MA)

• Visa Vs. Mastercard: Both Look Like Buys At Today's Prices (12/15)

Mattel (NYSE:MAT)

• Mattel - Is It Time To Play With This 4.8% Yielder At Last? (4/16)
• With Revenue Stabilization In 2015, Is Mattel An Attractive Buy Right Now? (2/16)
• Mattel Vs. Hasbro: Which Toy And Games Giant Should You Add To Your Portfolio? (12/15)

McCormick & Co (NYSE:MKC)

• Why Is McCormick Interested In Acquiring Premier Foods? (3/16)
• Food Fight, Part 7: McCormick Is A Spicy Long-Term Buy Despite Its Lofty Valuation (2/16)

Merck & Co (NYSE:MRK)

• Pfizer Inc Vs. Merck & Co: Which Pharmaceutical Giant Should You Buy? (5/16)

Microsoft (NYSE:MSFT)

• The FCF 5: Does Tech Giant Microsoft Pass My Free Cash Flow Tests? (1/16)

Nasdaq (NASDAQ:NDAQ)

• Have I Unfairly Overlooked NASDAQ And Intercontinental Exchange? (4/16)

Nike (NYSE:NKE)

• The FCF 5: Does Nike Pass My Five Free Cash Flow Tests? (1/16)

PepsiCo (NYSE:PEP)

• Coca-Cola Vs. PepsiCo: Both Great Companies But Both Are Running 11% Ahead Of Fair Value (12/15)

Pfizer (NYSE:PFE)

• Pfizer Inc Vs. Merck & Co: Which Pharmaceutical Giant Should You Buy? (5/16)
• The FCF 5: Does Pfizer Manage To Clear All 5 Of My Free Cash Flow Tests? (12/15)

Premier Foods (LSE:PFD)

• Why Is McCormick Interested In Acquiring Premier Foods? (3/16)

Procter & Gamble (NYSE:PG)

• Déjà Vu From Procter & Gamble? (4/16)
• Procter & Gamble: Efficiency Improvements Great, But Volume And Revenue Growth Needed To Continue Gains (2/16)
• Procter & Gamble Vs. Unilever: Which Consumer Staple Giant Should You Buy Right Now? (12/15)

PZ Cussons (LSE:PZC)

• PZ Cussons And The Nigerian Opportunity, Part 2: A Highly Attractive Long-Term Asset (4/16)
• PZ Cussons And The Nigerian Opportunity, Part 1: Why Nigeria Is Important In Understanding This Small Consumer Goods Play (4/16)

Ralph Lauren (NYSE:RL)

• The FCF 5: Does Ralph Lauren Pass My 5 Free Cash Flow Tests? (1/16)

Roper Technologies (NYSE:ROP)

• Roper Technologies: Hard To Fault Despite High Valuation And Low Yield (2/16)

Signet Jewelers (LSE:SIG) (NYSE:SIG)

• Signet Jewelers: Limp Historical Cash Flows Put Me Off, But Are They Set To Improve? (2/16)

Smith & Nephew (LSE:SN) (NYSE:SNN)

• MedTech, Part 1: Smith & Nephew - Attractive Valuation For Well-Placed, Solid Yielding Healthcare Giant (2/16)

Starbucks (NYSE:SBUX)

• A Slower Growing Starbucks Is No Less Attractive From A Free Cash Flow Perspective (But Maybe A Little Expensive) (1/16)
• The FCF 5: Does Coffee Giant Starbucks Pass My 5 Free Cash Flow Tests? (1/16)

Stryker (NYSE:SYK)

• MedTech, Part 2: Stryker - Peer-Beating Past Looks Set To Continue As Opportunities Remain Compelling (3/16)

Tyson Foods (NYSE:TSN)

• Tyson Foods: Was The 10% Jump On Q1 Results Justified? (2/16)
• Food Fight, Part 6: How Does The Transforming Tyson Foods Compare To Its Food Sector Peers? (1/16)

Unilever (LSE:ULVR) (NYSE:UL)

• Unilever: Just Keep Doing What You're Doing After Strong Q1 2016 Results (4/16)
• Unilever Remains Dividend Stalwart (1/16)
• Procter & Gamble Vs. Unilever: Which Consumer Staple Giant Should You Buy Right Now? (12/15)

United Technologies (NYSE:UTX)

• Should I Invest in Honeywell Or United Technologies? (3/16)

Verizon (NYSE:VZ)

• AT&T (T) vs. Verizon (VZ): Which Blue Chip Telecoms Play Should You Buy Today? (2/16)
• The FCF 5: Does Verizon Pass All My Free Cash Flow Tests? (1/16)

V. F. Corp (NYSE:VFC)

• After Recent Price Decline, Is Dividend Aristocrat VF Corp. Attractively Valued? (5/16)
• The FCF 5: Does Dividend Aristocrat V. F. Corp. Pass My 5 Free Cash Flow Tests? (1/16)

Visa (NYSE:V)

• Visa: Free Cash Flow Guidance May Be Due A Revision Too (Don't Worry Though) (4/16)
• Visa: Still Lithe And Limber (2/16)
• Visa Vs. Mastercard: Both Look Like Buys At Today's Prices (12/15)
• Visa Inc.'s Acquisition Of Visa Europe Makes It Even More Attractive As A Long-Term Investment (11/15)

Walt Disney (NYSE:DIS)

• Disney: Don't Get Too Distracted By Quarterly Results And The Reaction To Them (5/16)
• Diversifying Disney: Delights And Drawbacks (4/16)
• Walt Disney: It Has Now Hit My Fair Value Target - Time To Buy Or Back Off? (2/16)
• Walt Disney: Should You Be A Bear Or Bull? (1/16)